Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 12582
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
64957
Keep spinning bashers.You convince no one here.
(8)
Kelt
06/14/2020 2:11:39 PM
64956
IMO the least costly plan for the criminals is to
(5)
DoraBrown
06/14/2020 2:02:04 PM
64955
I am convinced that the criminals who have been
(18)
Mo
06/14/2020 1:41:45 PM
64954
The attached was posted by Drano on the
(11)
Mo
06/14/2020 11:06:12 AM
64953
FINRA short sales of IPIX
(5)
AlanC
06/12/2020 5:35:40 PM
64951
5 trades in a row of 4,500 shares. Kind of
(1)
Drano
06/12/2020 10:38:24 AM
64950
That would be amazing if we got funding for
(1)
DoraBrown
06/12/2020 10:07:33 AM
64949
Pete, if we get a large grant then I agree with
(4)
grotty
06/12/2020 9:47:07 AM
64948
I like the way we are trading early today. Change
(1)
grotty
06/12/2020 9:44:59 AM
64947
Im reposting this for reference. Pages 54-56
(11)
Ultimate
06/12/2020 9:11:04 AM
64946
Great post Pete....puts in perspective how
(4)
Chemdeps
06/12/2020 7:10:31 AM
64945
A while back one of IPIX's medical experts said
(14)
petemantx
06/11/2020 10:26:41 PM
64944
Bring it on!
(1)
AlanC
06/11/2020 7:42:49 PM
64943
Much more data now. They have kidney cell and
(10)
williamsc
06/11/2020 6:24:19 PM
64942
FINRA short sales of IPIX
(2)
AlanC
06/11/2020 5:59:07 PM
64941
Always good to have antagonism come out into the
(3)
Drano
06/11/2020 4:31:15 PM
64940
Pete, yes they do. You are probably not going to
(1)
sox0407
06/11/2020 4:06:01 PM
64939
If IPIX is generally effective against enveloped
(8)
Kelt
06/11/2020 3:37:58 PM
64938
Similar logic was used when IPIX applied for
(7)
sox0407
06/11/2020 3:26:50 PM
64937
The best drug becomes the drug of choice,
(5)
Drano
06/11/2020 3:25:37 PM
64936
Though it is very encouraging reading the updates
(3)
NotRichYet2
06/11/2020 3:19:56 PM
64935
The PR today noted the following: "Longer-term
(9)
petemantx
06/11/2020 2:44:05 PM
64934
I wonder if Leo is aware of this company and what
(3)
AlanC
06/11/2020 12:53:00 PM
64933
If it's for security of the research that makes
(1)
rocrelease
06/11/2020 12:06:48 PM
64932
How disappointing for hedge fund shorts that they
(11)
Drano
06/11/2020 11:57:18 AM
64931
I hope we don't know for sure until all testing
(4)
JPsooner
06/11/2020 11:56:26 AM
64930
I think today's news was decent--the silence was
(1)
rocrelease
06/11/2020 11:46:17 AM
64929
Today's news was exceptional IMO. All the
(10)
petemantx
06/11/2020 11:35:35 AM
64928
We know you're a multi-identity. You were outed
(4)
Drano
06/11/2020 11:26:47 AM
64927
Many at the swamp were fabricating stories of
(1)
DoraBrown
06/11/2020 11:21:55 AM
64926
No one was "complaining of tests being delayed"
(7)
Drano
06/11/2020 11:18:10 AM
64925
Does anyone know which of the prior tests this
(1)
DoraBrown
06/11/2020 10:57:36 AM
64924
Heavy volume today.
(2)
grotty
06/11/2020 10:42:45 AM
64923
So the lab is anxious to get government money to
(13)
Drano
06/11/2020 10:16:30 AM
64922
From 2/24 PR Should laboratory tests support
(2)
bettingbig
06/11/2020 10:10:09 AM
64921
So the Lung tissue study is not completed? Is
(1)
Jim Vernon
06/11/2020 10:04:03 AM
64920
Sure, let's draw conclusions about stock price
(2)
Drano
06/11/2020 9:55:59 AM
64918
Unfortunately this PR won't move the needle on
(1)
Waikikian
06/11/2020 9:27:57 AM
64917
Read that release on my I-Phone this morning. Our
(3)
NotRichYet2
06/11/2020 9:27:19 AM
64916
June 11 (Reuters) - Innovation Pharmaceuticals
(3)
PatiencePeople
06/11/2020 9:15:01 AM
64915
Like Ive said before, Brilacidin will be a
(6)
Ultimate
06/11/2020 9:00:03 AM
64914
Meanwhile MM bringing bid/ask
(2)
grotty
06/11/2020 8:45:05 AM
64913
Congrats Leo! PR worded a little differently but
(7)
PatiencePeople
06/11/2020 8:34:25 AM
64912
The science succeeds once again. Moving forward
(8)
AlanC
06/11/2020 8:28:36 AM
64911
Gee, I wonder if the test results were promising?
(7)
Drano
06/11/2020 8:15:28 AM
64910
PR this morning. Innovation Pharmaceuticals
(5)
Devo84
06/11/2020 7:39:57 AM
64909
Spot on . The short here is huge and I hope those
(5)
AlanC
06/11/2020 7:39:01 AM
64908
The usual narrative from the usual
(4)
Drano
06/10/2020 10:12:33 PM
64907
Maybe. But we're now printing at a rate of nearly
(4)
DoraBrown
06/10/2020 8:50:55 PM
64906
Don't they have to pay the MMs they employ
petemantx
06/10/2020 8:46:12 PM
Newer
Older
Recent Articles
Understanding the TikTok Deal: Implications for ByteDance's Future
C3.ai Faces Class Action Lawsuit: Key Details for Investors
Class Action Notice for KinderCare Investors Amid Concerns
Investors Alert: Participate in Class Action Against SOC Now
Flywire Corporation Lawsuit Highlights Investor Rights Overview
ACI Learning Partners with OMREN for Enhanced Cybersecurity Skills
China World Summit Wing’s Vertical Run: A Community Celebration
Celebrating the Legacy of the Kashi Fair: A Cultural Journey
L Catterton's Investment Fuels Seki Furniture's Growth
Unveiling New Partnerships at the 2025 Media Cooperation Forum
Cathie Wood's Bold Investment Moves: Key Stock Adjustments
Snap Inc. Accused of Misleading Statements in Lawsuit
Wanda L. James Unveils Congressional Campaign for Change
Qlarant Joins Agile4Vets to Enhance Veteran Healthcare Services
Qlarant Joins Forces to Transform Veteran Healthcare Services
Sable Offshore faces investor lawsuit over production claims
Coty's Stock Troubles: A Deeper Look into Retail Challenges
AI Startup Born Secures $15 Million to Combat Loneliness
Elcogen Unveils Cutting-Edge Manufacturing Facility for Clean Energy
Trailblazer Merger Corporation I Reschedules Annual Meeting
Understanding the Fluor Corporation Class Action Lawsuit Details
Explore Artistic Possibilities with Wacom One 14 Pen Display
Ubiqconn and RuggON Present Innovative Solutions at TADTE
KT&G Showcases ESSE at Intertabac 2025 to Boost Global Reach
Investors Concerns Over Fly-E Group, Inc. Amid Class Action
Understanding Class Action Opportunities for Savara Investors
Diversified Energy's Secondary Offering: Key Insights Ahead
Cygnus Metals Boosts Resource Estimate in Copper-Gold Project
V.F. Corporation Class Action Lawsuit: Key Information for Investors
Diversified Energy's Recent Ordinary Shares Offering Explained
Transforming Client Care: Emily Mehr's Role at Sweet James
Beauty Power's Nail Care Set Wins Prestigious Beauty Award
Former CIA Officer Discusses AI Project Impact on America
Elliott Investment Management's Support for Workday's Future
The Journey of a $1000 Microsoft Investment Over 20 Years
Clorox Company Announces New Quarterly Dividend of $1.24
Savara Inc. Investors Get Opportunity for Class Action Suit
Investors Take Action in Lockheed Martin Securities Case
Investigation Launch by Rosen Law for Encompass Health Investors
Elliott Investment Management's Progressive Outlook on Workday
Landmark Study Highlights NobleStitch™ PFO Closure Benefits
Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
Western Forest Products Secures New US$30 Million Credit Facility
Western Forest Products Secures a New $30 Million Credit Facility
Discover the Growth Potential of Progressive Investments
Altimmune Investors Urged to Act Before Class Action Deadline
Revolutionizing Storytelling: Verily Storyworks Emerges
Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status